Misplaced Pages

John Cunningham (physician)

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from John Cunningham (medical))

Sir John Cunningham KCVO FRCP (born 1949) is a British professor of nephrology at University College London Medical School and the Royal Free Hospital. He is a former physician to the Queen.

Biography

John Cunningham was born in 1949 and educated at Magdalen College School, Oxford, Trinity Hall, Cambridge (BA, 1970) and St John's College, Oxford (BM, BCh, 1973; DM, 1988). He also trained at Washington University School of Medicine, St. Louis, USA.

He became professor of nephrology at UCL Medical School, London and the Royal Free Hospital. He holds appointments at The London Clinic, and the King Edward VII Hospital, London.

He was Head of the Medical Household to Queen Elizabeth II from 2005 to 2014, and also occupied the position of Physician to the Queen. On stepping down, he was knighted by Queen Elizabeth II as a KCVO.

Selected publications

  • Achieving therapeutic targets in the treatment of secondary hyperparathyroidism.
  • New Vitamin D analogs and changing therapeutic paradigms.

See also

References

  1. ^ "Honours and Awards". The Gazette. 5 August 2014. Retrieved 9 September 2014.
  2. ^ ‘CUNNINGHAM, Prof. John’, Who's Who 2017, A & C Black, an imprint of Bloomsbury Publishing plc, 2017
  3. ^ "Professor John Cunningham – At the Limits". www.atthelimits.org. Retrieved 29 January 2022.
  4. Professor John Cunningham Archived October 4, 2013, at the Wayback Machine
  5. Malvern, Jack. "Duke of Edinburgh in hospital as chest infection makes him miss charity event". The Times. Archived from the original on 21 May 2021. Retrieved 21 May 2021.
  6. Wright, Paul (2 August 2014). "Former lead physician to the Queen and Royal Free professor knighted". Hampstead Highgate Express. Retrieved 29 January 2022.
  7. Achieving therapeutic targets in the treatment of secondary hyperparathyroidism
  8. New Vitamin D analogs and changing therapeutic paradigms
Categories: